Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

US President Trump announced deals with Novo Nordisk (NVO) and Eli Lilly (LLY) to secure lower prices of the companies' GLP-1 ...

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of ...

Pfizer's CEO certainly thinks so. In a TV interview, Bourla said: "Pfizer, when it plays, plays big. And we will -- as we did in COVID, as we did with Lipitor, as we did with ... Viagra, as we did ...

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 194 % ...

Eli Lilly partners with NVIDIA to build the world’s most powerful AI supercomputer in pharma, accelerating drug discovery and manufacturing innovation.

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Ireland’s leprechaun economics phase, coined after the economy grew by 26 per cent in 2016, came on foot of the iPhone ...